Latest Breaking News On - Nucleic acid production - Page 7 : comparemela.com

TriLink BioTechnologies, Part of Maravai LifeSciences,

DOD to fund planned manufacturing expansion and to prepare the U.S. for a rapid response to the next pandemic as part of Industrial Base Expansion.

Maravai LifeSciences Holdings, Inc. (MRVI) CEO Carl Hull on Q1 2022 Results - Earnings Call Transcript

Maravai LifeSciences Holdings, Inc. (NASDAQ:NASDAQ:MRVI) Q1 2022 Earnings Conference Call May 05, 2022, 05:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull -.

Contrasting Amicus Therapeutics (NASDAQ:FOLD) & Maravai LifeSciences (NASDAQ:MRVI)

Amicus Therapeutics (NASDAQ:FOLD – Get Rating) and Maravai LifeSciences (NASDAQ:MRVI – Get Rating) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations. Valuation and Earnings This table compares Amicus Therapeutics and […]

Maravai LifeSciences Announces March 2022 Investor Conference Schedule

09.03.2022 - SAN DIEGO, March 09, 2022 (GLOBE NEWSWIRE) - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor .

Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance